Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Application of the CRISPR/Cas9-based gene editing technique in basic research, diagnosis, and therapy of cancer
Huimin Zhang, Chunhong Qin, Changming An, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 170

Showing 26-50 of 170 citing articles:

Application of CRISPR-Cas9 gene editing technology in basic research, diagnosis and treatment of colon cancer
Hui Meng, Manman Nan, Yizhen Li, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 17
Advances in delivery systems for CRISPR/Cas-mediated cancer treatment: a focus on viral vectors and extracellular vesicles
Zhidu Song, Tao Ying, Yue Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Exploiting Nanotechnology for Drug Delivery: Advancing the Anti-Cancer Effects of Autophagy-Modulating Compounds in Traditional Chinese Medicine
Zixian Liu, Tianming Lu, Ruoning Qian, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 2507-2528
Open Access | Times Cited: 7
CRISPR/Cas9 application in cancer therapy: a pioneering genome editing tool
Sadegh Shojaei Baghini, Zhanna R. Gardanova, Saeme Azizi Hassan Abadi, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 24
Emerging Trends in Nano-Driven Immunotherapy for Treatment of Cancer
Gayathri Kandasamy, Yugeshwaran Karuppasamy, Uma Maheswari Krishnan
Vaccines (2023) Vol. 11, Iss. 2, pp. 458-458
Open Access | Times Cited: 16
CRISPR/Cas9-based application for cancer therapy: Challenges and solutions for non-viral delivery
Yingqi Lin, Ke-Ke Feng, Jie-Ying Lu, et al.
Journal of Controlled Release (2023) Vol. 361, pp. 727-749
Closed Access | Times Cited: 16
Whole genomic analysis reveals atypical non-homologous off-target large structural variants induced by CRISPR-Cas9-mediated genome editing
Hsiu‐Hui Tsai, Hsiao‐Jung Kao, Ming-Wei Kuo, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 13
Detection of Parasites in the Field: The Ever-Innovating CRISPR/Cas12a
Xin Li, Zhisheng Dang, Wenqiang Tang, et al.
Biosensors (2024) Vol. 14, Iss. 3, pp. 145-145
Open Access | Times Cited: 5
Mechanisms of Cancer Resistance to Various Therapies
Asiya Batool, Waseem Rashid, Kaneez Fatima, et al.
(2024), pp. 31-75
Closed Access | Times Cited: 5
Advancements of Gene Therapy in Cancer Treatment: A Comprehensive Review
Muhammad Dhiyauddin Mohd Abas, Muhammad Fareez Mohd Asri, Nur Anis Suffiah Yusafawi, et al.
Pathology - Research and Practice (2024) Vol. 261, pp. 155509-155509
Closed Access | Times Cited: 5
The transformative potential of AI-driven CRISPR-Cas9 genome editing to enhance CAR T-cell therapy
Alberto Boretti
Computers in Biology and Medicine (2024) Vol. 182, pp. 109137-109137
Closed Access | Times Cited: 5
CRISPR applications in cancer diagnosis and treatment
Mingxia Wang, Menghui Chen, Xia Wu, et al.
Cellular & Molecular Biology Letters (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 13
The NLRP3 inflammasome is a potential mechanism and therapeutic target for perioperative neurocognitive disorders
Jiayue Li, Li Li, Jiannan He, et al.
Frontiers in Aging Neuroscience (2023) Vol. 14
Open Access | Times Cited: 12
Magnetic‐Activated Nanosystem with Liver‐Specific CRISPR Nonviral Vector to Achieve Spatiotemporal Liver Genome Editing as Hepatitis B Therapeutics
Chenya Zhuo, Huiming Kong, Ke Yi, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 7
Closed Access | Times Cited: 12
Molecular Diagnosis and Cancer Prognosis—A Concise Review
Thatchanamoorthy Thenrajan, Subbiah Alwarappan, J. Wilson
Diagnostics (2023) Vol. 13, Iss. 4, pp. 766-766
Open Access | Times Cited: 12
A review of the literature on the use of CRISPR/Cas9 gene therapy to treat hepatocellular carcinoma
Elham Amjad, Raffaele Pezzani, Babak Sokouti
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 3, pp. 439-461
Open Access | Times Cited: 4
Review on Emerging Therapeutic Strategies for Managing Cardiovascular Disease
Minal Narkhede, Avinash Pardeshi, Rahul Bhagat, et al.
Current Cardiology Reviews (2024) Vol. 20, Iss. 4
Closed Access | Times Cited: 4
Revitalizing oral cancer research: Crispr-Cas9 technology the promise of genetic editing
S. Sowmya, Dominic Augustine, Shazia Mushtaq, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
Polymeric nanomaterials-based theranostic platforms for triple-negative breast cancer (TNBC) treatment
Sudhakar Reddy Baddam, Srinivas Ganta, Seshadri Nalla, et al.
International Journal of Pharmaceutics (2024) Vol. 660, pp. 124346-124346
Closed Access | Times Cited: 4
Extracellular Vesicles in Ovarian Cancer: From Chemoresistance Mediators to Therapeutic Vectors
Muttiah Barathan, Nur Dina Muhammad Fuad, Faizul Jaafar, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1806-1806
Open Access | Times Cited: 4
From regulation to deregulation of p53 in hematologic malignancies: implications for diagnosis, prognosis and therapy
Seyed Esmaeil Ahmadi, Elahe Rahimian, Samira Rahimi, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 4
CRISPR-Cas13 in malaria parasite: Diagnosis and prospective gene function identification
Elvis Quansah, Yihuan Chen, Shijie Yang, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 10
Peptide-Based Therapeutics in Cancer Therapy
Abduladheem Turki Jalil, Mohanad Ali Abdulhadi, Lubna R. Al-Ameer, et al.
Molecular Biotechnology (2023) Vol. 66, Iss. 10, pp. 2679-2696
Closed Access | Times Cited: 10
The Italian breakthrough in CRISPR trials for rare diseases: a focus on beta-thalassemia and sickle cell disease treatment
Francesca Greco, Marco Cosentino, Franca Marino
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 3
CRISPR-integrated metal-organic frameworks for biosensing applications: Recent advances and future perspective
Babak Mikaeeli Kangarshahi, Anahita Beigi, Seyed Morteza Naghib
Sensing and Bio-Sensing Research (2025), pp. 100736-100736
Open Access

Scroll to top